KMID : 0043320140370050626
|
|
Archives of Pharmacal Research 2014 Volume.37 No. 5 p.626 ~ p.635
|
|
In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system
|
|
Song Woo-Heon
Yeom Dong-Woo Lee Dong-Hoon Lee Kyung-Min Yoo Hyun-Joon Chae Bo-Ram Song Seh-Hyon Choi Young-Wook
|
|
Abstract
|
|
|
In order to characterize the in situ intestinal permeability and in vivo oral bioavailability of celecoxib (CXB), a poorly water-soluble cyclooxygenase (COX)-2 inhibitor, various formulations including the self-emulsifying drug delivery system (SEDDS) and supersaturating SEDDS (S-SEDDS) were compared. The S-SEDDS formulation was obtained by adding Soluplus as a precipitation inhibitor to SEDDS, composed of Capryol 90 as oil, Tween 20 as surfactant, and Tetraglycol as cosurfactant (1:4.5:4.5 in volume ratio). An in situ single pass intestinal perfusion study in rats was performed with CXB-dissolved solutions at a concentration of 40 ¥ìg/mL. The effective permeability (Peff) of CXB in the control solution (2.5 v/v% Tween 20-containing PBS) was 6.39 ¡¿ 10?5 cm/s. The Peff value was significantly increased (P < 0.05) by the lipid-based formulation, yielding 1.5- and 2.9-fold increases for the SEDDS and S-SEDDS solutions, respectively, compared to the control solution. After oral administration of various formulations to rats at the equivalent dose of 100 mg/kg of CXB, the plasma drug level was measured by LC?MS/MS. The relative bioavailabilities of SEDDS and S-SEDDS were 263 and 355 %, respectively, compared to the CXB suspension as a reference. In particular, S-SEDDS revealed the highest Cmax and the smallest Tmax, indicating rapid and enhanced absorption with this formulation. This study illustrates the potential use of the S-SEDDS formulation in the oral delivery of poorly water-soluble compounds.
|
|
KEYWORD
|
|
Celecoxib, SEDDS, Supersaturation, Soluplus, Intestinal permeability, Bioavailability
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|